創薬における構造生物学:手法・技術・事例<br>Structural Biology in Drug Discovery : Methods, Techniques, and Practices

個数:
電子版価格
¥37,594
  • 電子版あり

創薬における構造生物学:手法・技術・事例
Structural Biology in Drug Discovery : Methods, Techniques, and Practices

  • 在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
    通常6~9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合がございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版/ページ数 688 p.
  • 言語 ENG
  • 商品コード 9781118681015
  • DDC分類 615.19

Full Description

With the most comprehensive and up-to-date overview of structure-based drug discovery covering both experimental and computational approaches, Structural Biology in Drug Discovery: Methods, Techniques, and Practices describes principles, methods, applications, and emerging paradigms of structural biology as a tool for more efficient drug development. Coverage includes successful examples, academic and industry insights, novel concepts, and advances in a rapidly evolving field.

The combined chapters, by authors writing from the frontlines of structural biology and drug discovery, give readers a valuable reference and resource that:



Presents the benefits, limitations, and potentiality of major techniques in the field such as X-ray crystallography, NMR, neutron crystallography, cryo-EM, mass spectrometry and other biophysical techniques, and computational structural biology
Includes detailed chapters on druggability, allostery, complementary use of thermodynamic and kinetic information, and powerful approaches such as structural chemogenomics and fragment-based drug design
Emphasizes the need for the in-depth biophysical characterization of protein targets as well as of therapeutic proteins, and for a thorough quality assessment of experimental structures
Illustrates advances in the field of established therapeutic targets like kinases, serine proteinases, GPCRs, and epigenetic proteins, and of more challenging ones like protein-protein interactions and intrinsically disordered proteins

Contents

List of Contributors

Preface

Chapter 01: The Evolving Role of Structural Biology in Drug Discovery

Chapter 02: A Structural View on Druggability: Experimental and Computational Approaches

Chapter 03: Structural Chemogenomics: Profiling Protein-Ligand Interactions in Polypharmacological Space

Chapter 04: Fragment-Based Ligand Discovery

Chapter 05: Combining Structural, Thermodynamic and Kinetic Information to Drive Hit-to-Lead Progression

Chapter 06: Allostery as Structure-Encoded Collective Dynamics: Significance in Drug Design

Chapter 07: Biophysical Assessment of Target Protein Quality in Structure-Based Drug discovery

Chapter 08: An Industrial Perspective on Protein-Ligand Complex Crystallization

Chapter 09: Membrane Protein Crystallization

Chapter 10: High-throughput Macromolecular Crystallography in Drug Discovery: Evolving in the Midst of Revolutions

Chapter 11: Assessment of Crystallographic Structure Quality and Protein - Ligand Complex Structure Validation

Chapter 12: Complementary Information from Neutron Crystallography Studies

Chapter 13: Determination of Protein Structure and Dynamics by NMR: State of the Art and Application to the Characterization of Biotherapeutics

Chapter 14: NMR Studies of Protein - Small Molecule Interactions for Drug Discovery

Chapter 15: Computational Structural Biology for Drug Discovery: Power and Limitations

Chapter 16: The Role of Structural Biology in Kinase Inhibitors Drug Discovery Success

Chapter 17: Serine Proteinases from the Blood Coagulation Cascade

Chapter 18: Epigenetic Proteins as Emerging Drug Targets

Chapter 19: Impact of Recently Determined Crystallographic Structures of GPCRs on Drug Discovery

Chapter 20: Targeting Protein-Protein Interactions Perspective

Chapter 21: Mass Spectrometry-Based Strategies for Therapeutic Antibodies Extensive Characterization and Optimization (OptimAbs)

Chapter 22: Integrating Evolution of Drug Resistance into Drug Discovery: Lessons from the Viral Proteases of HIV-1 and HCV

Chapter 23: A Comprehensive Review on Mycobacterium Tuberculosis Targets and Drug Development from a Structural Perspective

Chapter 24: Using Crystal Structures of Drug-Metabolizing Enzymes in Mechanism-Based Modeling for Drug Design

Chapter 25: Intrinsically Disordered Proteins (IDPs): Targets for the Future?

Chapter 26: Cryo-electron Microscopy as a Tool for Drug Discovery in the Context of Integrative Structural Biology

Chapter 27: Application of Hard-X-ray Free-electron Lasers for Static and Dynamic Processes in Structural Biology

最近チェックした商品